January 2025 – Page 3

Secretary Rubio Expands Humanitarian Exemptions in US Foreign Aid Freeze

3 months ago talkbio0Tagged Freezing, global health programs, Humanitarian Exemptions, International Aspects, Manufactured Supplies, Marco Rubio, United States Agency for International Development

Marco Rubio, foreign aid freeze, humanitarian exemptions, USAID, medicine supplies, global health programs

Senate Hearing for RFK Jr. Amid Strong Public Support for Vaccine Access

3 months ago talkbio0Tagged Department of Health and, FDA-approved, Hearing, Homo sapiens, public entity, RFK Jr., Senate, Services, United States Food and Drug Administration, Vaccines

RFK Jr., Senate hearing, vaccine access, public support, FDA-approved vaccines, Department of Health and Human Services nomination

Zentalis Pharmaceuticals Cuts Workforce by 40% to Advance WEE1 Inhibitor to Registrational Trial

3 months ago talkbio0Tagged Cancer Therapeutic Procedure, Clinical Trials, Industry, Inhibitor, WEE1, WEE1 gene, Zentalis

Zentalis Pharmaceuticals, layoffs, WEE1 inhibitor, azenosertib, clinical trials, cancer treatment, biotech industry

FDA Postpones Opioids Advisory Committee Meeting and Cancels Kidney Drug Review

3 months ago talkbio0Tagged Advisory Committees, Analgesics, Opioid, cancellation, kidney drug, regulatory meetings, United States Food and Drug Administration

FDA, advisory committee, postponement, cancellation, opioids, kidney drug, regulatory meetings

RFK Jr. Faces Intense Scrutiny in Senate Confirmation Hearings for HHS Secretary

3 months ago talkbio0Tagged Confirmation, doubt, Health, Hearings, Human Services Secretary, Republican, Robert F. Kennedy, Senate, stance, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., Senate confirmation hearings, Health and Human Services Secretary, Trump nominee, vaccine stance, Republican doubts

Delaware Court Ruling Paves Way for Aurion Biotech IPO, Alcon to Appeal Decision

3 months ago talkbio0Tagged Alcon, biotech, Bovichtus, Court of Chancery, Delaware, IPO, research, Reverse Stock Split, Series

Aurion Biotech, Alcon Research, IPO, Delaware Court of Chancery, reverse stock split, voting proxy, Series C consent rights

FDA Approves Ozempic for Reducing Kidney Disease Risks in Adults with Type 2 Diabetes and Chronic Kidney Disease

3 months ago talkbio0Tagged Agonist, Approved, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes, GLP-1 receptor, Kidney Diseases, Ozempic, Risk, semaglutide, United States Food and Drug Administration

Ozempic, FDA Approval, Type 2 Diabetes, Chronic Kidney Disease (CKD), Kidney Disease Risks, Cardiovascular Disease Risks, Semaglutide, GLP-1 Receptor Agonist

ITM’s Radiopharmaceutical ITM-11 Shows Promising Results in Phase III COMPOSE Trial for Advanced Neuroendocrine Tumors

3 months ago talkbio0Tagged COMPOSE trial, GEP-NETs, ITM-11, Neoplasms, Neurosecretory Systems, Radionuclide therapy

ITM-11, neuroendocrine tumors, GEP-NETs, COMPOSE trial, targeted radionuclide therapy, 177Lu-edotreotide

Amgen and Celltrion Reach Settlement in Denosumab Patent Litigation, Paving Way for Mid-2025 Biosimilar Launch

3 months ago talkbio0Tagged amgen, Biosimilars, Celltrion, denosumab, launch, Legal patent, Litigation, settlement

Amgen, Celltrion, denosumab, patent litigation, biosimilar, settlement, launch date

Leap Therapeutics’ Stock Plummets Following Disappointing DKK1 Antibody Results in Gastric Cancer Trials

3 months ago talkbio0Tagged Antibodies, Clinical Trials, DKK1 gene, LEAP, Malignant neoplasm of stomach, Performance

Leap Therapeutics, DKK1 Antibody, Gastric Cancer, Clinical Trials, Stock Performance